XBiotech Inc. (NASDAQ:XBIT) today announced that its Investigational New Drug (IND) application for

IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path f

XBiotech (NASDAQ:XBIT) reported quarterly losses of $(0.18) per share. This is a 50 percent increase

IN8bio (NASDAQ: INAB - Get Free Report) and XBiotech (NASDAQ: XBIT - Get Free Report) are both small

Psyence Biomedical (NASDAQ: PBM - Get Free Report) and XBiotech (NASDAQ: XBIT - Get Free Report) are

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

XBiotech Inc. (NASDAQ: XBIT - Get Free Report) passed above its 50 day moving average during trading

XBiotech (NASDAQ:XBIT) reported quarterly losses of $(0.20) per share. This is a 25 percent decrease

XBiotech (NASDAQ:XBIT) reported quarterly losses of $(0.06) per share. This is a 86.05 percent incre

LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder righ

LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder righ

LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 27, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 26, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 23, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 22, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 21, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 20, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 19, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 17, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 16, 2025 / The Schall Law Firm, a national shareholder

LOS ANGELES, CA / ACCESS Newswire / February 15, 2025 / The Schall Law Firm, a national shareholder

XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, hig

XBiotech (NASDAQ:XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, place

XBiotech Inc. (NASDAQ:XBIT) Announces that Hutrukin is being developed by XBiotech as a breakthrough

XBiotech Inc. announced today completion of enrollment of the Phase II portion of its 1-BETTER study

 XBiotech Inc. (NASDAQ:XBIT) today began treating the first patient in a phase II, double-blind, pla

Gainers

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday

 XBiotech Inc. (NASDAQ:XBIT) has enrolled the first subject in a randomized, open-label, placebo-con

  On Monday, 79 companies reached new 52-week lows.

  Thursday saw 177 companies set new 52-week lows.

XBiotech (NASDAQ:XBIT) announced today the enrollment of the first patient in a multicenter, randomi

  On Thursday, 1076 companies hit new 52-week lows.

  On Tuesday, 507 stocks hit new 52-week lows.

  On Monday, 429 stocks made new 52-week lows.

  On Wednesday, 238 companies achieved new lows for the year.

  On Monday, 273 companies set new 52-week lows.

  On Monday, 195 stocks hit new 52-week lows.

  On Friday, 109 stocks hit new 52-week lows.

  On Monday, 92 companies set new 52-week lows.

  On Thursday, 550 companies achieved new lows for the year.

Here's a roundup of top developments in the biotech space over the last 24 hours:

  During the Thursday's session, 100 stocks hit new 52-week lows.

  On Tuesday, 540 companies set new 52-week lows.